Giordano, Sharon Hermes
- University of Puerto Rico Medical Sciences · Internal Medicine (NIH department code)
- UT MD Anderson Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #7,500
- Program Leader
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2004 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#7,500
By linked amount among FY2023 PIs
Earliest Year Loaded
2004
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Giordano, Sharon Hermes as a PI. Multi-PI records show the full award amount for context.
- 5U54CA096297-20U54Contact PIUPR/MDACC: Partnership for Excellence in Cancer Research (2 of 2)University of Puerto Rico Medical Sciences · Internal Medicine (NIH department code)$1.1Maward amount
- 5R01AR078484-03R01Contact PIEffects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes$213.8Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Giordano, Sharon Hermes as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2004First NIH AwardUniversity of Puerto Rico Medical Sciences
- 2005Multi-Institutional ResearchAwards at 2 institutions
- 2005R01 Grant Holder
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #6267
- 2021Program/Center Grant Leader
- 2022$2M Cumulative Funding